1. OP0189 Tumor necrosis factor inhibitor treatment reduces spinal radiographic progression in ankylosing spondylitis by decreasing disease activity: a longitudinal analysis in a large prospective cohort. (15th June 2017) Authors: Molnar, C; Scherer, A; Baraliakos, X; Hooge, M de; Micheroli, R; Exer, P; Kissling, R; Tamborrini, G; Wildi, L; Nissen, M; Zufferey, P; Bernhard, J; Weber, U; Landewé, R; Heijde, D van der; Ciurea, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry. (15th June 2017) Authors: Finckh, A; Herzog, L; Scherer, A; Dudler, J; Moeller, B; Ciurea, A; Mueller, R; Hasler, P; Exer, P; Muehlenen, I von; Kyburz, D; Gabay, C; Zufferey, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0347 Impact of obesity on the response to tumour necrosis factor inhibitors in axial spondyloarthritis. (15th June 2017) Authors: Micheroli, R; Hebeisen, M; Scherrer, A; Wildi, L; Exer, P; Tamborrini, G; Bernhard, J; Möller, B; Zufferey, P; Nissen, MJ; Ciurea, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗